Benoit Christophe Stephan Callendret

USPTO Granted Patents = 11 (Patent Applications = 4)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

Leiden, NL (2020)
The Hague, NL (2019 - 2024)

Company Filing History:

11 out of 115

Janssen Vaccines & Prevention B.v.

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 2019-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11918639 - Methods and compositions for inducing protective immunity against filovirus infection (2024-03-05),

2. 11896663 - Immunodeficiency virus type 1 (HIV-1) mutant envelope proteins (2024-02-13),

3. 11229695 - Method for the safe induction of immunity against RSV (2022-01-25),

4. 11173204 - MVA-BN and Ad26.ZEBOV or Ad26.filo prime-boost regimen (2021-11-16),

5. 11173201 - Methods and compositions for inducing protective immunity against filovirus infection (2021-11-16),

6. 10973907 - Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigens (2021-04-13),

7. 10925956 - Methods and compositions for inducing protective immunity against a marburg virus infection (2021-02-23),

8. 10925955 - Methods and compositions for inducing protective immunity against a Marburg virus infection (2021-02-23),

9. 10561722 - Methods and compositions for enhancing immune responses (2020-02-18),

10. 10561721 - Methods and compositions for inducing protective immunity against filovirus infection (2020-02-18),

11. 10369214 - Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereof (2019-08-06),

Title: Inventor Spotlight: Benoit Christophe Stephan Callendret

Introduction:

Meet Benoit Christophe Stephan Callendret, a prolific inventor based in The Hague, NL, with an impressive portfolio of 11 patents. His groundbreaking work focuses on developing methods and compositions for inducing protective immunity against filovirus infections and synthetic HIV envelope proteins to combat HIV.

Latest Patents:

Callendret's latest patents showcase his innovative approach to vaccine development:

1. Methods and compositions for inducing protective immunity against filovirus infection.

2. Immunodeficiency virus type 1 (HIV-1) mutant envelope proteins.

Career Highlights:

During his career, Benoit Christophe Stephan Callendret has made significant contributions to the field of immunology and vaccine research. He has worked with esteemed companies such as Janssen Vaccines & Prevention B.V. and Bavarian Nordic A/S, where he has spearheaded projects aimed at combating infectious diseases.

Collaborations:

Throughout his career, Callendret has collaborated closely with talented individuals in the field, including Ariane Volkmann and Robin Steigerwald. These collaborations have led to the development of innovative vaccine strategies and enhanced protective immunity against deadly viruses.

Conclusion:

In conclusion, Benoit Christophe Stephan Callendret stands out as a visionary inventor in the realm of immunology and vaccine development. His dedication to advancing scientific knowledge and improving global health outcomes is truly commendable. We look forward to witnessing more groundbreaking inventions from this talented individual in the future.

This text is generated by artificial intelligence and may not be accurate.